Detail akcie NeuroPace Rg online

Business Summary: NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Neuropace Inc revenues increased 26% to $73.4M. Net loss decreased 14% to $18.7M. Revenues reflect Medical Device segment increase of 87% to $73.4M, United States segment increase of 87% to $73.4M. Basic Earnings per Share excluding Extraordinary Items increased from -$0.76 to -$0.58.